Literature DB >> 31621381

LncRNA WT1-AS Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Downregulating Transforming Growth Factor β1.

Jiangfen Wang1, Chunfang Xi1, Xuan Yang1, Xiaoting Lu1, Keda Yu2, Yafen Zhang1, Runfang Gao1.   

Abstract

Background: Long noncoding RNA WT1-AS has been demonstrated as a potential tumor suppressor in gastric cancer. However, the functions of WT1-AS in other types of cancer remain unclear. Our study was therefore performed to explore the role of WT1-AS in triple-negative breast cancer (TNBC). Materials and
Methods: Tissue specimens were obtained from 62 TNBC patients included in this study. A TNBC cell line BT-549 was used as the cell model of TNBC. Gene expression was detected by qPCR and Western blot. Overexpression experiments were used to analyze gene interactions. Transwell assays were used to explore the effects of transfections on cell invasion and migration.
Results: We found that WT1-AS was downregulated in TNBC tissues than in nontumor tissues and decreased with increase in clinical stages. Transforming growth factor β1 (TGF-β1) was upregulated in TNBC tissues and inversely correlated with WT1-AS. TGF-β1 overexpression did not significantly affect WT1-AS in BT-549 cells, but WT1-AS negatively regulated the expression of TGF-β1. WT1-AS overexpression caused inhibited migration and invasion of TNBC cells. TGF-β1 overexpression showed opposite functions and reduced the effects of WT1-AS overexpression.
Conclusion: WT1-AS may downregulate TGF-β to inhibit the migration and invasion of TNBC cells.

Entities:  

Keywords:  TGF-β1; WT1-AS; invasion; migration; triple-negative breast cancer

Mesh:

Substances:

Year:  2019        PMID: 31621381     DOI: 10.1089/cbr.2019.2925

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  7 in total

Review 1.  The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer.

Authors:  Utpalendu Paul; Satarupa Banerjee
Journal:  Mol Biol Rep       Date:  2022-03-02       Impact factor: 2.742

Review 2.  The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis.

Authors:  Haomeng Zhang; Jiao Wang; Yulong Yin; Qingjie Meng; Yonggang Lyu
Journal:  Biosci Rep       Date:  2021-02-26       Impact factor: 3.840

3.  Genome wide methylation profiling of selected matched soft tissue sarcomas identifies methylation changes in metastatic and recurrent disease.

Authors:  Ana Cristina Vargas; Lesley-Ann Gray; Christine L White; Fiona M Maclean; Peter Grimison; Nima Mesbah Ardakani; Fiona Bonar; Elizabeth M Algar; Alison L Cheah; Peter Russell; Annabelle Mahar; Anthony J Gill
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

4.  NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641.

Authors:  Yan Zhong; Weiwei Zeng
Journal:  J Healthc Eng       Date:  2022-01-17       Impact factor: 2.682

5.  lncRNA WT1-AS attenuates hypoxia/ischemia-induced neuronal injury during cerebral ischemic stroke via miR-186-5p/XIAP axis.

Authors:  Jianquan You; Fei Qian; Yu Huang; Yingxuan Guo; Yaqian Lv; Yuqi Yang; Xiupan Lu; Ting Guo; Jun Wang; Bin Gu
Journal:  Open Med (Wars)       Date:  2022-07-25

6.  A prognostic nomogram based on competing endogenous RNA network for clear-cell renal cell carcinoma.

Authors:  Yun Peng; Shangrong Wu; Zihan Xu; Dingkun Hou; Nan Li; Zheyu Zhang; Lili Wang; Haitao Wang
Journal:  Cancer Med       Date:  2021-06-30       Impact factor: 4.452

7.  Long non-coding RNA SNHG8 enhances triple-negative breast cancer cell proliferation and migration by regulating the miR-335-5p/PYGO2 axis.

Authors:  Jintao Qian; Xinhan Lei; Yue Sun; Lu Zheng; Jia Li; Shuai Zhang; Lei Zhang; Wanwan Li; Jianing Shi; Wenjun Jia; Tong Tang
Journal:  Biol Direct       Date:  2021-08-06       Impact factor: 4.540

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.